Update: 15.01.2024
Last week: 52 week 2023 (25.12.2023 - 31.12.2023)
Last full month: December 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 244 376 | -7.0% | 3.7% | -0.2 | 60 481 268 | -7.7% | 3.5% | -0.2 | -2.6% |
| MoM | 1 029 648 | 60.0% | 3.6% | 0.5 | 256 410 026 | 60.6% | 3.5% | 0.4 | 35.8% |
| YTD | 5 949 736 | -39.6% | 3.0% | -1.8 | 1 484 892 124 | -26.5% | 3.3% | -1.4 | -4.5% |
| MAT | 5 949 736 | -39.6% | 3.0% | -1.8 | 1 484 892 124 | -26.5% | 3.3% | -1.4 | -4.5% |
| DEXALGIN | |||||||||
| WoW | 27 091 | 5.1% | 0.4% | 0 | 14 130 083 | 5.2% | 1.1% | 0 | 4.2% |
| MoM | 107 950 | 24.4% | 0.4% | 0 | 55 804 859 | 25.4% | 1.1% | 0 | 21.9% |
| YTD | 992 752 | -37.4% | 0.4% | -0.2 | 513 392 293 | -25.2% | 1.1% | -0.6 | 1.6% |
| MAT | 992 752 | -37.4% | 0.4% | -0.2 | 513 392 293 | -25.2% | 1.1% | -0.6 | 1.6% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 72 918 | 4.4% | 38.6% | -0.8 | 43 844 436 | 6.2% | 44.6% | -0.5 | 6.7% |
| MoM | 308 053 | 2.0% | 39.8% | -0.7 | 181 692 958 | 4.1% | 45.8% | 0 | 3.8% |
| YTD | 3 156 622 | -26.3% | 39.6% | -13.7 | 1 868 444 438 | -15.4% | 46.5% | -12.5 | -0.9% |
| MAT | 3 156 622 | -26.3% | 39.6% | -13.7 | 1 868 444 438 | -15.4% | 46.5% | -12.5 | -0.9% |
| ESPUMISAN BABY | |||||||||
| WoW | 27 132 | 4.4% | 33.8% | -0.5 | 25 889 801 | 6.2% | 51.7% | -0.5 | 5.8% |
| MoM | 116 629 | -0.6% | 34.4% | -0.2 | 107 767 667 | 11.3% | 52.0% | 1.6 | 0.1% |
| YTD | 1 211 016 | -15.1% | 32.7% | -4.6 | 934 037 453 | 3.1% | 48.1% | -2.5 | -3.1% |
| MAT | 1 211 016 | -15.1% | 32.7% | -4.6 | 934 037 453 | 3.1% | 48.1% | -2.5 | -3.1% |
| FASTUM | |||||||||
| WoW | 21 834 | -0.3% | 1.1% | 0 | 13 315 926 | -0.4% | 2.6% | 0 | -2.7% |
| MoM | 92 652 | 29.6% | 1.0% | 0.2 | 56 452 780 | 30.7% | 2.6% | 0.5 | 2.1% |
| YTD | 829 114 | -20.3% | 0.9% | -0.3 | 500 630 570 | -8.4% | 2.2% | -0.3 | 4.8% |
| MAT | 829 114 | -20.3% | 0.9% | -0.3 | 500 630 570 | -8.4% | 2.2% | -0.3 | 4.8% |
| IODOMARIN | |||||||||
| WoW | 80 721 | -2.3% | 27.4% | 0.2 | 14 566 670 | -1.8% | 9.9% | 0 | -2.9% |
| MoM | 363 387 | 4.4% | 27.5% | 0.3 | 65 168 342 | 4.7% | 10.0% | 0 | 3.3% |
| YTD | 3 720 154 | 13.0% | 25.6% | 3.9 | 674 242 847 | 5.4% | 9.5% | 0.4 | -4.4% |
| MAT | 3 720 154 | 13.0% | 25.6% | 3.9 | 674 242 847 | 5.4% | 9.5% | 0.4 | -4.4% |
| LIOTON | |||||||||
| WoW | 19 378 | -3.0% | 2.1% | 0 | 21 644 310 | -3.4% | 3.8% | -0.2 | -1.5% |
| MoM | 82 827 | 4.7% | 2.1% | 0.1 | 94 589 643 | 0.7% | 3.9% | 0 | -0.5% |
| YTD | 1 002 786 | -19.9% | 2.1% | -0.4 | 1 223 732 474 | -6.4% | 4.3% | -0.3 | -3.1% |
| MAT | 1 002 786 | -19.9% | 2.1% | -0.4 | 1 223 732 474 | -6.4% | 4.3% | -0.3 | -3.1% |
| MEZYM | |||||||||
| WoW | 361 718 | 35.1% | 19.4% | 2.5 | 66 211 783 | 33.8% | 14.2% | 1.6 | 17.6% |
| MoM | 1 216 499 | 17.8% | 17.4% | 0.9 | 220 645 050 | 22.3% | 12.8% | 1.1 | 11.4% |
| YTD | 11 652 276 | -32.8% | 17.8% | -7.6 | 1 932 925 547 | -26.9% | 12.6% | -5.5 | -4.3% |
| MAT | 11 652 276 | -32.8% | 17.8% | -7.6 | 1 932 925 547 | -26.9% | 12.6% | -5.5 | -4.3% |
| MIG 400 | |||||||||
| WoW | 195 690 | 13.3% | 2.7% | 0.2 | 26 011 969 | 13.3% | 2.0% | 0.1 | 4.2% |
| MoM | 753 128 | 20.1% | 2.6% | 0 | 99 918 950 | 20.4% | 1.9% | 0 | 21.9% |
| YTD | 6 743 310 | -19.7% | 2.5% | -0.7 | 867 845 616 | -12.7% | 1.9% | -0.5 | 1.6% |
| MAT | 6 743 310 | -19.7% | 2.5% | -0.7 | 867 845 616 | -12.7% | 1.9% | -0.5 | 1.6% |
| PROSTAMOL | |||||||||
| WoW | 28 331 | -3.7% | 14.0% | -0.4 | 47 898 801 | -3.2% | 17.1% | -0.3 | -1.0% |
| MoM | 125 659 | 7.4% | 14.2% | 0.4 | 211 275 883 | 11.0% | 17.3% | 1 | 4.3% |
| YTD | 1 169 186 | -24.4% | 13.6% | -4.6 | 1 831 359 893 | -15.4% | 15.5% | -3.8 | 1.4% |
| MAT | 1 169 186 | -24.4% | 13.6% | -4.6 | 1 831 359 893 | -15.4% | 15.5% | -3.8 | 1.4% |
| RESPERO MYRTOL | |||||||||
| WoW | 51 483 | -3.1% | 10.2% | 0.2 | 28 186 258 | -2.9% | 9.7% | 0 | -5.1% |
| MoM | 217 928 | 53.0% | 9.4% | 1.3 | 118 226 488 | 57.8% | 9.3% | 0.9 | 31.9% |
| YTD | 1 271 753 | -2.3% | 7.8% | -0.6 | 687 551 034 | 10.3% | 8.2% | -0.2 | 5.1% |
| MAT | 1 271 753 | -2.3% | 7.8% | -0.6 | 687 551 034 | 10.3% | 8.2% | -0.2 | 5.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 5 949 736 | -39.6% | 3.0% | -1.8 | 1 484 892 124 | -26.5% | 3.3% | -1.4 | -4.5% |
| DEXALGIN | 992 752 | -37.4% | 0.4% | -0.2 | 513 392 293 | -25.2% | 1.1% | -0.6 | 1.6% |
| ESPUMISAN (ADULTS) | 3 156 622 | -26.3% | 39.6% | -13.7 | 1 868 444 438 | -15.4% | 46.5% | -12.5 | -0.9% |
| ESPUMISAN BABY | 1 211 016 | -15.1% | 32.7% | -4.6 | 934 037 453 | 3.1% | 48.1% | -2.5 | -3.1% |
| FASTUM | 829 114 | -20.3% | 0.9% | -0.3 | 500 630 570 | -8.4% | 2.2% | -0.3 | 4.8% |
| IODOMARIN | 3 720 154 | 13.0% | 25.6% | 3.9 | 674 242 847 | 5.4% | 9.5% | 0.4 | -4.4% |
| LIOTON | 1 002 786 | -19.9% | 2.1% | -0.4 | 1 223 732 474 | -6.4% | 4.3% | -0.3 | -3.1% |
| MEZYM | 11 652 276 | -32.8% | 17.8% | -7.6 | 1 932 925 547 | -26.9% | 12.6% | -5.5 | -4.3% |
| MIG | 6 743 310 | -19.7% | 2.5% | -0.7 | 867 845 616 | -12.7% | 1.9% | -0.5 | 1.6% |
| PROSTAMOL | 1 169 186 | -24.4% | 13.6% | -4.6 | 1 831 359 893 | -15.4% | 15.5% | -3.8 | 1.4% |
| RESPERO MYRTOL | 1 271 753 | -2.3% | 7.8% | -0.6 | 687 551 034 | 10.3% | 8.2% | -0.2 | 5.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 5 949 736 | -39.6% | 3.0% | -1.8 | 1 484 892 124 | -26.5% | 3.3% | -1.4 | -4.5% |
| DEXALGIN | 992 752 | -37.4% | 0.4% | -0.2 | 513 392 293 | -25.2% | 1.1% | -0.6 | 1.6% |
| ESPUMISAN (ADULTS) | 3 156 622 | -26.3% | 39.6% | -13.7 | 1 868 444 438 | -15.4% | 46.5% | -12.5 | -0.9% |
| ESPUMISAN BABY | 1 211 016 | -15.1% | 32.7% | -4.6 | 934 037 453 | 3.1% | 48.1% | -2.5 | -3.1% |
| FASTUM | 829 114 | -20.3% | 0.9% | -0.3 | 500 630 570 | -8.4% | 2.2% | -0.3 | 4.8% |
| IODOMARIN | 3 720 154 | 13.0% | 25.6% | 3.9 | 674 242 847 | 5.4% | 9.5% | 0.4 | -4.4% |
| LIOTON | 1 002 786 | -19.9% | 2.1% | -0.4 | 1 223 732 474 | -6.4% | 4.3% | -0.3 | -3.1% |
| MEZYM | 11 652 276 | -32.8% | 17.8% | -7.6 | 1 932 925 547 | -26.9% | 12.6% | -5.5 | -4.3% |
| MIG | 6 743 310 | -19.7% | 2.5% | -0.7 | 867 845 616 | -12.7% | 1.9% | -0.5 | 1.6% |
| PROSTAMOL | 1 169 186 | -24.4% | 13.6% | -4.6 | 1 831 359 893 | -15.4% | 15.5% | -3.8 | 1.4% |
| RESPERO MYRTOL | 1 271 753 | -2.3% | 7.8% | -0.6 | 687 551 034 | 10.3% | 8.2% | -0.2 | 5.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 244 376 | -7.0% | 3.7% | -0.2 | 60 481 268 | -7.7% | 3.5% | -0.2 | -2.6% |
| DEXALGIN | 27 091 | 5.1% | 0.4% | 0 | 14 130 083 | 5.2% | 1.1% | 0 | 4.2% |
| ESPUMISAN (ADULTS) | 72 918 | 4.4% | 38.6% | -0.8 | 43 844 436 | 6.2% | 44.6% | -0.5 | 6.7% |
| ESPUMISAN BABY | 27 132 | 4.4% | 33.8% | -0.5 | 25 889 801 | 6.2% | 51.7% | -0.5 | 5.8% |
| FASTUM | 21 834 | -0.3% | 1.1% | 0 | 13 315 926 | -0.4% | 2.6% | 0 | -2.7% |
| IODOMARIN | 80 721 | -2.3% | 27.4% | 0.2 | 14 566 670 | -1.8% | 9.9% | 0 | -2.9% |
| LIOTON | 19 378 | -3.0% | 2.1% | 0 | 21 644 310 | -3.4% | 3.8% | -0.2 | -1.5% |
| MEZYM | 361 718 | 35.1% | 19.4% | 2.5 | 66 211 783 | 33.8% | 14.2% | 1.6 | 17.6% |
| MIG | 195 690 | 13.3% | 2.7% | 0.2 | 26 011 969 | 13.3% | 2.0% | 0.1 | 4.2% |
| PROSTAMOL | 28 331 | -3.7% | 14.0% | -0.4 | 47 898 801 | -3.2% | 17.1% | -0.3 | -1.0% |
| RESPERO MYRTOL | 51 483 | -3.1% | 10.2% | 0.2 | 28 186 258 | -2.9% | 9.7% | 0 | -5.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 1 029 648 | 60.0% | 3.6% | 0.5 | 256 410 026 | 60.6% | 3.5% | 0.4 | 35.8% |
| DEXALGIN | 107 950 | 24.4% | 0.4% | 0 | 55 804 859 | 25.4% | 1.1% | 0 | 21.9% |
| ESPUMISAN (ADULTS) | 308 053 | 2.0% | 39.8% | -0.7 | 181 692 958 | 4.1% | 45.8% | 0 | 3.8% |
| ESPUMISAN BABY | 116 629 | -0.6% | 34.4% | -0.2 | 107 767 667 | 11.3% | 52.0% | 1.6 | 0.1% |
| FASTUM | 92 652 | 29.6% | 1.0% | 0.2 | 56 452 780 | 30.7% | 2.6% | 0.5 | 2.1% |
| IODOMARIN | 363 387 | 4.4% | 27.5% | 0.3 | 65 168 342 | 4.7% | 10.0% | 0 | 3.3% |
| LIOTON | 82 827 | 4.7% | 2.1% | 0.1 | 94 589 643 | 0.7% | 3.9% | 0 | -0.5% |
| MEZYM | 1 216 499 | 17.8% | 17.4% | 0.9 | 220 645 050 | 22.3% | 12.8% | 1.1 | 11.4% |
| MIG | 753 128 | 20.1% | 2.6% | 0 | 99 918 950 | 20.4% | 1.9% | 0 | 21.9% |
| PROSTAMOL | 125 659 | 7.4% | 14.2% | 0.4 | 211 275 883 | 11.0% | 17.3% | 1 | 4.3% |
| RESPERO MYRTOL | 217 928 | 53.0% | 9.4% | 1.3 | 118 226 488 | 57.8% | 9.3% | 0.9 | 31.9% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs